CGON

Cg Oncology Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 6/10
  • Momentum↑ 9/10
Cg Oncology sales and earnings growth
CGON Growth
Good
  • Revenue Y/Y↑ 217.84%
  • EPS Y/Y↑ 62.29%
  • FCF Y/Y↓ -61.06%
Cg Oncology gross and profit margin trends
CGON Profitability
Neutral
  • Gross margin ↑ 27.50%
  • EPS margin↓ -6968.00%
  • ROIC↓ -24.80%
Cg Oncology net debt vs free cash flow
CGON Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Cg Oncology stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗